In 2024, Vanderbilt Health investigators received funding from the National Institute on Aging (NIA) for a phase 3, multicenter, placebo-controlled trial to evaluate the efficacy of the ...
In a recent study published in Nature Communications, researchers explored the roles of acute-phase virological dynamics and host immunological responses in post-acute infection sequelae of ...
A mobile phone application can characterize patterns of recovery from neurological manifestations of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC), with ...
In most cases of multisystem inflammatory syndrome in children, a rare condition that can occur after a COVID infection, kids present with gastrointestinal symptoms. In this small placebo-controlled ...
BLOOM (TAMPA) – Chiropractic physician Dr. Cathleen Gerenger joined Gayle Guyardo, host of the global health and wellness show Bloom, to discuss long COVID symptoms and the findings of a recent Yale ...
Q: What are the current treatments for post-acute infection syndrome, and why have some failed to be effective? Currently, there are no FDA-approved treatments for ME/CFS or long COVID. However, ...
In an unusual move, the FDA asked vaccine makers to conduct randomized studies evaluating possible long-term effects of the COVID-19 shot, including spike persistence and post-vaccination syndrome ...
News-Medical.Net on MSN
A common diabetes drug may prevent long COVID when taken early
By Dr. Priyom Bose, Ph.D. Large clinical trials and real-world data point to a familiar diabetes drug as a simple, safe way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results